Marketed in the past by AstraZeneca as Pulmicort, budesonide is an off-patent inhaled steroid and could be used to prevent the risk of people getting seriously ill with the disease, if taken ...

Objective: To review the basis for the estimated comparative daily dosages of inhaled corticosteroids for children and adults that are presented in the National Heart, Lung, and Blood Institute's ...

Learn how systemic glucocorticoids, used for treating inflammatory conditions, are linked to a significantly higher risk of ...

You should stop taking any long-acting inhalers which contain inhaled corticosteroids or bronchodilators. However, you can continue to use a quick-acting inhaler (such as VENTOLIN) during an acute ...

Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not ...

Adding GSK’s mepolizumab to standard inhaled treatment for COPD reduces the frequency of exacerbations in patients with type ...

Patients being treated with steroids are more than twice as likely to develop diabetes, Oxford scientists have found.

The phase IIIA trials randomized 792 patients ages 12 and older with severe asthma in a 2:1 ratio to depemokimab (100 mg ...

Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester, shares findings from the FLAME trial on blood eosinophil changes in patients with chronic ...

Glucocorticoids (sometimes known as steroids) fight inflammation and are used to treat a wide range of inflammatory and autoimmune conditions, including asthma, rheumatoid arthritis, cancers and other ...

Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, the Annual Meeting of the European Association for ...

Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not ...